Literature DB >> 11346392

Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers.

E Letko1, S U Stechschulte, K R Kenyon, N Sadeq, T R Romero, C M Samson, Q D Nguyen, S L Harper, J D Primack, D T Azar, M Gruterich, C H Dohlman, S Baltatzis, C S Foster.   

Abstract

OBJECTIVES: To determine the effect of amniotic membrane transplantation (AMT) on persistent corneal epithelial defects (PEDs) and to compare the efficacy between inlay and overlay techniques.
METHODS: Thirty patients (30 eyes) underwent AMT for PED. The use of AMT was restricted to patients in whom all previous measures, including bandage contact lens and tarsorrhaphy, had failed. The amniotic membrane was placed on the surface of the cornea in overlay (group A) or inlay (group B) fashion.
RESULTS: The PED healed after the first AMT in 21 eyes (70%) within an average of 25.5 days after surgery and recurred in 6 eyes (29%). Among the 22 eyes treated with an overlay AMT (group A), the PED healed after the first AMT in 14 eyes (64%) within an average of 24.5 days and recurred in 4 eyes (29%). Among the 8 eyes treated with an inlay AMT (group B), the PED healed within an average of 27.4 days after AMT, which did not statistically significantly differ from group A (P = .72). The PED healed after the first AMT in 7 eyes (88%) and recurred in 2 (29%) of 7 eyes.
CONCLUSIONS: The AMT can be helpful in the treatment of PED in which all other conventional management has failed. However, the success rate in our study was not as high as that previously reported, and our results showed a high incidence of recurrences of epithelial defects. We did not find any difference between overlay and inlay techniques in terms of healing time and recurrence rate.

Entities:  

Mesh:

Year:  2001        PMID: 11346392     DOI: 10.1001/archopht.119.5.659

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  26 in total

1.  Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group.

Authors:  Valerie P J Saw; Darwin Minassian; John K G Dart; Andrew Ramsay; Hugo Henderson; Stefan Poniatowski; Ruth M Warwick; Suzanne Cabral
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

Review 2.  [Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects].

Authors:  B Seitz
Journal:  Ophthalmologe       Date:  2007-12       Impact factor: 1.059

3.  Role of multilayered amniotic membrane transplantation for the treatment of resistant corneal ulcers in North India.

Authors:  Shalini Mohan; Ina Budhiraja; Amit Saxena; Perwez Khan; S K Sachan
Journal:  Int Ophthalmol       Date:  2013-07-27       Impact factor: 2.031

4.  Comparative proteomic analysis of amnion membrane transplantation and cross-linking treatments in an experimental alkali injury model.

Authors:  Sevgi Subasi; Ozgul Altintas; Murat Kasap; Nil Guzel; Gurler Akpinar; Suleyman Karaman
Journal:  Int Ophthalmol       Date:  2017-11-23       Impact factor: 2.031

5.  Ultrastructural analysis of in vivo expanded corneal epithelium on amniotic membrane.

Authors:  Hyo Shin Ha; Kye Yong Song; Jae Chan Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

6.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

7.  Canine amniotic membrane transplantation for corneal reconstruction after the excision of dermoids in dogs.

Authors:  Marissak Kalpravidh; Pranee Tuntivanich; Simon Vongsakul; Sudson Sirivaidyapong
Journal:  Vet Res Commun       Date:  2009-09-17       Impact factor: 2.459

8.  Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.

Authors:  A Heiligenhaus; H Li; E E Hernandez Galindo; J M Koch; K-P Steuhl; D Meller
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

Review 9.  Human amniotic membrane transplantation: Different modalities of its use in ophthalmology.

Authors:  Chintan Malhotra; Arun K Jain
Journal:  World J Transplant       Date:  2014-06-24

Review 10.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.